Immuneering Q1 EPS $(0.21) Beats $(0.26) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsNews
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 50 percent increase over losses of $(0.42) per share from the same
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 50 percent increase over losses of $(0.42) per share from the same period last year.